- $88.65m
- $78.46m
- $67.35m
- 58
- 48
- 67
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.11 | 6.21 | 9 | 22 | 67.4 |
Cost of Revenue | |||||
Gross Profit | -0.154 | -0.711 | -0.972 | -1.67 | 1.2 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.38 | 11.4 | 15.6 | 41.7 | 83.6 |
Operating Profit | -3.27 | -5.21 | -6.6 | -19.7 | -16.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.93 | -5.21 | -6.6 | -19.7 | -16 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.93 | -5.21 | -6.6 | -19.7 | -16.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.93 | -5.21 | -6.6 | -19.7 | -16.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.93 | -5.21 | -6.6 | -19.7 | -16.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.881 | -0.845 | -0.743 | -1.99 | -1.3 |